Privacy Policy

Delta-Fly Pharma, Inc. (hereinafter referred to as “the Company”) handles personal information in an appropriate manner according to this Privacy Policy (hereinafter referred to as “the Policy”) in addition to complying with related laws and guidelines concerning the protection of personal information.

1 Legal Basis for Handling of Personal Information

  1. (1)The Company will handle personal information in accordance with the Policy. Individuals who provide personal information to the Company will be considered to have consented to the handling of personal information in accordance with the Policy.
  2. (2)The consent under (1) above may be withdrawn at any time. Individuals who wish to withdraw their consent are asked to contact the Company using the addressee information indicated under “7 Point of Contact for Handling of Personal Information” below.
  3. (3)The provision of personal information to the Company is optional. However, individuals who do not provide personal information may be unable to use all or part of the products, services, benefits, etc. provided by the Company.
  4. (4)In cases based on the following ground or where permitted by laws and regulations, the Company may handle personal information regardless of whether it has the consent of the individual.
    1. When the handling of personal information is necessary for the performance of a contract which the individual is party to or in order to take steps at the request of the individual prior to entering into a contract.
    2. When the handling of personal information is necessary for compliance with a legal obligation which the Company is subject.
    3. When the handling of personal information is necessary in order to protect the vital interests of the individual or of another natural person.
    4. When the handling of personal information is necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the Company.
    5. When the handling of personal information is necessary for purposes of the legitimate interests pursued by the Company or by a third party.

2 Collection and Use of Personal Information

  1. (1)The Company will collect personal information in an appropriate and lawful manner to use for the purposes of use set forth in the Policy.
  2. (2)The Company will use personal information to the extent necessary to achieve its business purposes, and will not use personal information for purposes outside the scope without the consent of the individual. Additionally, the Company will not conduct automated processing, profiling included, with respect to personal information.
  3. (3)When it no longer needs to use personal information for its business purposes, the Company will delete that personal information without delay. The Company will use the following as its standards when determining the retention period for personal information.
    1. The quantity, nature and confidentiality of personal information.
    2. Risks upon the leakage of personal information and the need to hold that information.
    3. The presence of a duty to retain personal information under the law and other legal, tax-based or accounting requirements.

3 Purpose of Use of Personal Information

The Company will use the following personal information for the purposes of use indicated below.

  1. (1)Personal information of medical personnel and researchers
    1. Provision and collection of information on the proper use of pharmaceuticals
    2. Provision and collection of information on the quality, safety or efficacy of pharmaceuticals
    3. Research in the medical and pharmaceutical fields
    4. Provision and collection of medical and academic information
    5. Requests for and implementation of clinical trials, post-marketing surveys, etc.
    6. Notifications, reports, and applications to government offices
  2. (2)Personal information of users
    1. Provision and collection of information on the proper use of pharmaceuticals
    2. Provision and collection of information on the quality, safety, or efficacy of pharmaceuticals
    3. Provision and collection of medical, academic, and product information
    4. Notification and reporting to government offices
    5. Consideration and responses to consultations and inquiries
    6. Communication and provision of information to product manufacturers, distributors, medical professionals, etc.
  3. (3)Personal information of shareholders
    1. Exercise of rights and performance of obligations under the Companies Act
    2. Provision of information from the Company to shareholders
    3. Implementation of measures to facilitate the relationship between the Company and shareholders
    4. Business management based on standards, laws and regulations
    5. Consideration and responses to consultations and inquiries
  4. (4)Personal information of media and investors ① Provision and collection of information for public relations
    1. Provision and collection of information for public relations activities
    2. Administrative contact for public relations activities
  5. (5)Personal information of officers and employees of business partners
    1. Communication regarding transactions, provision of information, and establishment of relationships
    2. Receivables management based on laws and regulations
  6. (6)Personal information of employment candidates
    1. Communication regarding hiring decisions
  7. (7)Personal Information of Officers, Employees, Retirees ①
    1. Communication to and various procedures for labor unions, health insurance groups, corporate pension funds, welfare mutual aid associations, affiliated companies, etc.
    2. Notification and reporting to government offices

4 Provision of Personal Information to Third Parties

The Company will not provide personal information to third parties without the prior consent of the individual, except as required by law.

5 Secure Management Measures

An overview of the measures for the secure management of personal information set forth by the Company is as follows.

Secure management measure itemsOverview of measures
Formulation of basic policyThe Company thoroughly protects personal information in accordance with the Policy.
Establishment of discipline pertaining to handling of personal informationThe Company appoints a managing supervisor for the handling of personal information and handles that information with precision in accordance with internal regulations.
Organizational secure management measuresThe Company clarifies the roles and responsibilities of the managing supervisor for personal information and the officers and employees who actually handle that information, and prepares a liaison and response system for cases where personal information leaks, etc. arise.
Human secure management measuresThe Company continuously and regularly conducts education and training in order to ensure that its officers and employees recognize the importance of protecting personal information and implement that protection certainly.
Physical secure management measuresThe Company thoroughly manages personal information using passwords, locking and other means in order to prevent leaks, etc. of that information.
Technical secure management measuresThe Company adequately controls access to systems for handling personal information and takes measures to prevent illegal access to those systems.
Ascertainment of external environmentThe Company adequately ascertains the systems, etc. of foreign countries and take measures necessary to securely manage personal data in cases where it handles that data overseas.

6 Rights to Disclosure, Etc. of Personal Information

  1. (1)Individuals identified based on personal information held by the Company have the rights below (hereinafter referred to as “rights to the disclosure, etc. of personal information, etc.”) in accordance with the laws and regulations.
    1. Right to request the disclosure of or access to personal information or records of the provision thereof to third parties.
    2. Right to request the correction, addition or deletion of content comprising personal information.
    3. Right to request the suspension of use or deletion of personal information or the suspension of the provision thereof to third parties.
    4. Right to demand that restrictions on the handling of personal information be obtained from the Company.
    5. Right to object to the handling of personal information.
    6. Right to data portability.
  2. (2)Individuals who wish to exercise their rights to the disclosure, etc. of personal information, etc. are asked to contact the Company using the addressee information indicated under “7 Point of Contact for Handling of Personal Information” below. After taking proper procedures to verify the individual, the Company will respond without delay to a reasonable extent in accordance with laws and regulations.

7 Point of Contact for Handling of Personal Information

The point of contact at the Company for the handling of personal information is as follows. Please contact the below to withdraw consent to the handling of personal information, to exercise rights to the disclosure, etc. of personal information, etc. held by the Company or to notify the company of any complaints or other inquiries as set forth in the Policy.

Delta-Fly Pharma, Inc.
Nihonbashi Life Science Building 2, 6th Floor
3-11-5 Nihonbashi-honcho, Chuo-ku, Tokyo, 103-0023 Japan
TEL +81 (03)-6231-1278 (main)

8 Use of Cookies

当社は、The Company uses cookies to investigate the usage status of the website that it operates (hereinafter referred to as the “Company’s website”) and to improve the user experience of that website. A cookie is a data file that a website sends to users’ computer so that when they visit the same website again, it will be recognized that the website is accessed from the same user’s computer. Without the consent of the individual, the Company’s website does not collect information that can identify individuals by using cookies, such as their name, address, telephone number, or e-mail address.

9 Revision of Policy

The Company may revise the Policy as necessary. In the event of a revision to the Policy, the Company will disclose the effective date and contents of the revised Policy by displaying them on the Company’s website or through other appropriate methods, or will provide notification of them to the individual.

11 Business Operator Handling Personal Information

Kiyoshi Eshima, President
Delta-Fly Pharma, Inc.
37-5 Nishikino, Miyajima, Kawauchi-cho, Tokushima-shi, Tokushima, 771-0116
Japan